ライフサイエンスコーパス: cancer survivor

1 der neck contractures (BNCs) in the prostate cancer survivor.

2 o meet the demand of an increasing number of cancer survivors.

3 ny of the CVRFs increased the risk of CVD in cancer survivors.

4 ies investigating chronic pain management in cancer survivors.

5 rm the reproductive counseling of female AYA cancer survivors.

6 vidence-based weight management programs for cancer survivors.

7 ascular homeostasis and long-term effects on cancer survivors.

8 etes, dyslipidemia) on long-term CVD risk in cancer survivors.

9 ase inhibitor (AI) use on CVD risk in breast cancer survivors.

10 ovascular health of patients with cancer and cancer survivors.

11 ing treatment and chronic persistent pain in cancer survivors.

12 s are associated with outcomes in colorectal cancer survivors.

13 on radiation-induced myopathy (RIM) in adult cancer survivors.

14 ced arthralgia in previously inactive breast cancer survivors.

15 fects quality of life in pediatric and adult cancer survivors.

16 g about imaging were especially important to cancer survivors.

17 ociated Medicare costs in early-stage breast cancer survivors.

18 undergoing cancer treatment and 2) childhood cancer survivors.

19 noses and deaths and make up the majority of cancer survivors.

20 l cancer-specific mortality among colorectal cancer survivors.

21 ublic stigma is a major source of stress for cancer survivors.

22 lity, and patient activation among long-term cancer survivors.

23 S is associated with cessation rates in lung cancer survivors.

24 n be expanded to improve outcomes for breast cancer survivors.

25 nce (FCR) is a common problem experienced by cancer survivors.

26 er in certain subpopulations, such as breast cancer survivors.

27 nd can greatly affect the quality of life of cancer survivors.

28 ent approaches have demonstrated efficacy in cancer survivors.

29 onsistently discussing and providing SCPs to cancer survivors.

30 c stigma on psychological distress in Korean cancer survivors.

31 ancers ranged from 3% to 8% in this group of cancer survivors.

32 vance to the increasing numbers of long-term cancer survivors.

33 antial with an increasing number of prostate cancer survivors.

34 ntion may improve HRQOL among elderly female cancer survivors.

35 cantly greater risk of CBC than other breast cancer survivors.

36 ry habits, and body mass index in colorectal cancer survivors.

37 lth and behavioral outcomes among colorectal cancer survivors.

38 effective strategies for managing the RTW of cancer survivors.

39 of various screening strategies for affected cancer survivors.

40 ional cross-sectional survey involving 4,270 cancer survivors.

41 hildhood, adolescent, and young adult (CAYA) cancer survivors.

42 rsonalized care in limiting neurotoxicity in cancer survivors.

43 s also were greater among HCT versus non-HCT cancer survivors.

44 y in U-shaped pattern among long-term breast cancer survivors.

45 ed with morbidity and functional problems in cancer survivors.

46 n male pubertal, adolescent, and young adult cancer survivors.

47 to enhance evidence-based care for male CAYA cancer survivors.

48 ly affect reproductive outcomes among female cancer survivors.

49 gher (or lower) than average risk for breast cancer survivors.

50 gnitive impairment is reported frequently by cancer survivors.

51 lp to preserve long-term health of pediatric cancer survivors.

52 ated with late morbidity and mortality among cancer survivors.

53 t in the effect of cardiovascular disease on cancer survivors.

54 thy (CIPN) is a major cause of disability in cancer survivors.

55 ng the functional impact of CIPN symptoms on cancer survivors.

56 Among the 2,548 colorectal cancer survivors, 1,074 died during follow-up, including

57 ospitalization compared with matched non-HCT cancer survivors (280 v 173 episodes per 1,000 person-ye

58 s 3.1% in female and 3.7% in male colorectal cancer survivors, 3.0% in breast cancer survivors, and 2

59 Methods Participants included 982 cancer survivors (9 to 26 years of age; 1 to 5 years pos

60 oss intervention for African American breast cancer survivors (AABCS) on weight, body composition, an

61 verse health status outcomes among childhood cancer survivors across 3 decades.

62 verse health status outcomes among childhood cancer survivors across 3 decades.

63 that aim to integrate PCPs into the care of cancer survivors across different settings.

64 Native T1 and ECV remained elevated in cancer survivors after accounting for demographics (incl

65 leading cause of morbidity and mortality in cancer survivors after recurrent malignancy.

66 essful metastasis prevention in asymptomatic cancer survivors after surgery.

67 The US population of cancer survivors age >/= 65 years will continue to grow

68 terial financial hardship was more common in cancer survivors age 18 to 64 years than in those >/= 65

69 In adjusted analyses, cancer survivors age 18 to 64 years who were younger, fe

70 thods A secondary data analysis of 512 women cancer survivors (age, 62 +/- 6 years; time since diagno

71 risk for systolic CHF among 5-year childhood cancer survivors aged 15 years was 18.8% without routine

72 rom June 1, 2010, to January 22, 2013, using cancer survivors, ages 7 to 17 years, who were previousl

73 reast cancer survivors, and 2.1% in prostate cancer survivors (all P < .001).

74 We identified 741 cancer survivors and 10,472 non-cancer participants.

75 CI 7.7-16.2) in the pooled sample of 51 381 cancer survivors and 10.2% (8.0-12.6) in 217 630 healthy

76 xiety was 17.9% (95% CI 12.8-23.6) in 48 964 cancer survivors and 13.9% (9.8-18.5) in 226 467 healthy

77 hour admissions, 58 healthy women (38 breast cancer survivors and 20 demographically similar control

78 .5 h admissions, 58 healthy women (38 breast cancer survivors and 20 demographically similar controls

79 xpenditure Panel Survey, we identified 4,960 cancer survivors and 64,431 individuals without a histor

80 morbidity development over time among breast cancer survivors and a noncancer control group.

81 e and birth between childhood and adolescent cancer survivors and an age-matched comparison group.

82 Cancer survivors and comparisons were followed up for ho

83 n could dramatically improve the outlook for cancer survivors and enable more effective use of radiat

84 of obesity increased from 22.4% to 31.7% in cancer survivors and from 20.9% to 29.5% in adults witho

85 equent, late side effects of radiotherapy in cancer survivors and have a detrimental impact on their

86 significant effect on the severity of FCR in cancer survivors and is a promising new treatment approa

87 Colorectal and breast cancer survivors and non-Hispanic blacks were identified

88 significant weight loss in African American cancer survivors and of maintaining weight loss in any c

89 Fatigue is prevalent in cancer survivors and often causes significant disruption

90 se of a remarkable increase in the number of cancer survivors and the proliferation of new cancer the

91 nition and treatment of anxiety in long-term cancer survivors and their spouses.

92 und surveillance mammography in older breast cancer survivors and to consider cessation while taking

93 and quality of life vs usual care in breast cancer survivors and to determine if changes were sustai

94 examine the evidence of accelerated aging in cancer survivors and to determine the responsible mechan

95 Results Six new randomized trials in breast cancer survivors and two randomized trials in endometria

96 referred treatment for diabetes among breast cancer survivors and whether it benefits breast cancer p

97 colorectal cancer survivors, 3.0% in breast cancer survivors, and 2.1% in prostate cancer survivors

98 ty and time to pregnancy in female childhood cancer survivors, and analysed treatment characteristics

99 diagnosis increases second cancer risk among cancer survivors, and elevated cancer risk in these surv

100 den were colorectal cancer survivors, breast cancer survivors, and non-Hispanic blacks.

101 Purpose Cancer survivors are at high risk for human papillomavir

102 Colorectal cancer survivors are at risk for poor health outcomes be

103 ctive data evaluating its efficacy in female cancer survivors are lacking.

104 Data on smoking and second cancer risk among cancer survivors are limited.

105 Conclusion HPV vaccine initiation rates in cancer survivors are low.

106 Breast cancer survivors are more likely to develop mood disorde

107 cess of basic and disease-specific research, cancer survivors are one of the largest growing subsets

108 aging biomarkers of interstitial fibrosis in cancer survivors are related to prior receipt of a poten

109 portant complication that affects testicular cancer survivors as a consequence of treatment.

110 two post-treatment assessments of 200 breast cancer survivors assigned to either 12 weeks of 90-minut

111 birth outcomes of adolescent and young adult cancer survivors (AYA [diagnosed at ages 15-39 years]) w

112 Early breast cancer survivors (BCSs) report high unmet care needs, an

113 al symptoms and quality of life among breast cancer survivors (BCSs) who completed treatment.

114 ality of life (secondary outcomes) in breast cancer survivors (BCSs) with a DSM-IV diagnosis of a sex

115 Dyspareunia is common in breast cancer survivors because of low estrogen.

116 of increasing obesity burden were colorectal cancer survivors, breast cancer survivors, and non-Hispa

117 y is a prime concern in both male and female cancer survivors, but endocrine effects of gonadal damag

118 lity of life for the post-treatment prostate cancer survivor by comprehensively addressing components

119 Childhood cancer survivors carry a high burden of treatment-relate

120 Adult childhood cancer survivors (CCSs) are at high risk for illness and

121 Purpose Childhood cancer survivors (CCSs) are at increased risk for subseq

122 , obesity increased more rapidly among adult cancer survivors compared with the general population.

123 o elevated second cancer risks in colorectal cancer survivors compared with the general population.

124 icular focus on three populations: childhood cancer survivors, congenital heart disease patients, and

125 However, childhood cancer survivors' coverage priorities and familiarity wi

126 apy (bCBT) can reduce the severity of FCR in cancer survivors curatively treated for breast, prostate

127 spective, multicenter cohort study of 5-year cancer survivors diagnosed before age 21 years from pedi

128 obability of having a first live birth among cancer survivors diagnosed during childhood or adolescen

129 gistry (CCR) was used to identify female AYA cancer survivors diagnosed from January 2000 to December

130 We identified 1,202 adult cancer survivors diagnosed or treated at >/= 18 years of

131 In this Series paper, we define the term cancer survivor, discuss survivors' ongoing needs and pr

132 Pain is a common problem in cancer survivors, especially in the first few years afte

133 Cancer survivors, especially the working-age population,

134 tudy is a prospective cohort study of breast cancer survivors established in 2006.

135 With the number of cancer survivors expanding quickly, the time has come fo

136 By and large, NHB and Hispanic childhood cancer survivors experience a comparable burden of morbi

137 d cerebral microbleeds (CMBs) between breast cancer survivors exposed to adjuvant radiotherapy and ch

138 Conclusion Childhood cancer survivors exposed to CRT and subsequently diagnos

139 Childhood cancer survivors exposed to pulmonary-toxic therapy are

140 Cancer survivors face a variety of challenges as they co

141 of the brain, heart, and joints of pediatric cancer survivors for chemotherapy-induced injuries in on

142 conversations regarding weight management in cancer survivors, fostering a robust research agenda, an

143 Follow-up of adult-onset cancer survivors given cisplatin should include routine

144 vivors and of maintaining weight loss in any cancer survivor group.

145 Among cancer survivors >/= 65 years of age, those who were you

146 es in the general US population, female PAYA cancer survivors had a 40% relative excess of HPV-associ

147 All cancer survivors had a higher risk of developing a secon

148 Conversely, prostate cancer survivors had a lower CVD risk (IRR, 0.89; P < .0

149 Births to AYA cancer survivors had a significantly increased prevalenc

150 Eight of 10 cancer survivors had abnormal findings on brain, heart,

151 Overall, cancer survivors had more than two-fold risk of developi

152 Both HCT and non-HCT cancer survivors had significantly greater 10-year cumul

153 Over time, breast cancer survivors had significantly higher tumor necrosis

154 Methotrexate-treated cancer survivors had significantly lower cerebral blood

155 Although the number of cancer survivors has increased substantially in the past

156 cer therapy on health status among childhood cancer survivors has not been evaluated.

157 cer therapy on health status among childhood cancer survivors has not been evaluated.

158 of hospitalization in this specific group of cancer survivors has not been thoroughly evaluated.

159 diac morbidity and mortality among childhood cancer survivors have been described previously.

160 trials addressing energy balance factors in cancer survivors have not answered and to develop a road

161 t of potential adverse effects could improve cancer survivors' health and quality of life.

162 apping characteristics are elevated in adult cancer survivors; however, it remains unknown whether th

163 management and regular physical activity in cancer survivors; however, lifestyle interventions are n

164 morbidity and mortality in radiation-treated cancer survivors; however, the long-term effects on the

165 ffects for managing hot flashes among breast cancer survivors; however, these preliminary findings ne

166 ty lowers risk of mortality among colorectal cancer survivors; however, trials have shown that physic

167 Among 32,447 cancer survivors identified, the most common cancer diag

168 ormancy in healthy individuals as well as in cancer survivors; (ii) cancer metastasis could be an ear

169 on CVD in a cohort of postmenopausal breast cancer survivors in analyses that accounted for major CV

170 vance the integration of PCPs in the care of cancer survivors in diverse clinical settings.

171 Our findings may pertain to cancer survivors in general, underlining the importance

172 logy service providers to identify childhood cancer survivors in need of psychosocial services and pr

173 e sub-ethnic groups of Asian American breast cancer survivors in order to propose future directions f

174 the prevalence of obesity and inactivity in cancer survivors in the United States and elsewhere, ene

175 amined the trend in obesity prevalence among cancer survivors in the United States in the past two de

176 Conclusion Cancer survivors in the United States reported medicatio

177 ion-based data to estimate the percentage of cancer survivors in the United States reporting current

178 n of interventions in diverse populations of cancer survivors, including answering critical questions

179 As the population of head and neck cancer survivors increases, it has become increasingly i

180 ement in self-reported cognitive function in cancer survivors, indicating that this intervention is a

181 Public stigma perceived by cancer survivors influenced psychological distress via c

182 anding risk factors for second cancers among cancer survivors is crucial.

183 The first generation of childhood cancer survivors is now aging into their fourth and fift

184 Currently, the approach to managing pain in cancer survivors is similar to that for chronic cancer-r

185 nce, in managing all areas of care for adult cancer survivors, is variable with deficits in important

186 structured exercise, is safe for colorectal cancer survivors (localized to metastatic stage, during

187 e of Medicine report: From cancer patient to cancer survivor: lost in transition, in 2005, there has

188 te of Medicine Report From Cancer Patient to Cancer Survivor: Lost in Transition.

189 omes, and determine the best methods to help cancer survivors make effective and useful changes in li

190 Childhood cancer survivors may be at risk for impaired psychosexua

191 Live births to AYA cancer survivors may have an increased risk of preterm b

192 imaging data acquired from 62 primary breast cancer survivors (mean [SD] age, 54.7 [8.5] years) who w

193 Overall, 2598 births to AYA cancer survivors (mean [SD] maternal age, 31 [5] years)

194 Among cancer survivors, mortality risk by CVD status was exami

195 New or worsening pain in a cancer survivor must be evaluated to determine whether t

196 otoxicity in a cohort of long-term childhood cancer survivors (N = 108) who received anthracyclines a

197 view Survey, years 2010 to 2013, identifying cancer survivors (n = 3,184) and adults with no history

198 Education and assistance, perhaps through cancer survivor navigation, are critically needed to ens

199 lap between these diseases, with millions of cancer survivors now at risk of developing CVD.

200 Moreover, because more than 40% of cancer survivors now live longer than 10 years, there is

201 or associated with smoking cessation in lung cancer survivors of all stages and should be a key consi

202 portant priority for the long-term health of cancer survivors of both sexes and all ages at treatment

203 to 2.93) when compared with patients without cancer; survivors of leukemia and breast cancer were at

204 hout cancer was selected and matched 10:1 to cancer survivors on the basis of age, sex, Kaiser Perman

205 nd 18 months after primary cancer treatment (cancer survivors) or within a comparable time frame (con

206 Weight loss interventions among breast cancer survivors positively affect weight, behavior, bio

207 sease, these methods need further testing in cancer survivors post-treatment and in patients with end

208 e part of the treatment strategy for pain in cancer survivors, prescribed with the aim of restoring f

209 d the 10 earlier randomized trials in female cancer survivors provide support for the feasibility of

210 it is reasonable to propose that we are all cancer survivors rather than cancer-free individuals bec

211 Breast cancer survivors received care equivalent to controls on

212 We conducted, in 121 breast cancer survivors receiving an AI and reporting arthralgi

213 Cancer survivors seek the resumption of a normal and hea

214 sight) and compared it with standard care in cancer survivors self-reporting cognitive symptoms.

215 If health care providers are to transform cancer survivor services then investment is required in

216 This study of over 200 000 cancer survivors shows that age at cancer diagnosis was

217 mmit on Advancing Obesity Clinical Trials in Cancer Survivors sought to identify the knowledge gaps t

218 in 12,316 5-year survivors in the Childhood Cancer Survivor Study (2,002 with and 10,314 without abd

219 Survivors in the Childhood Cancer Survivor Study (CCSS) free of significant cardiov

220 ts and Methods Participants in the Childhood Cancer Survivor Study (CCSS; n = 13,060) were observed t

221 Cohort Study (n = 1,695), and the Childhood Cancer Survivor Study (n = 12,407).

222 The Teenage and Young Adult Cancer Survivor Study cohort comprises 200 945 5-year su

223 ality among 34,033 patients in the Childhood Cancer Survivor Study cohort who survived at least 5 yea

224 We used data from a subset of the Childhood Cancer Survivor Study cohort, which followed 5-year surv

225 m similarly treated members of the Childhood Cancer Survivor Study cohort.

226 survivors and 390 siblings in the Childhood Cancer Survivor Study completed the Brief Symptom Invent

227 The Childhood Cancer Survivor Study is a multicentre, North American s

228 The British Childhood Cancer Survivor Study is a population-based cohort of 34

229 tcomes in aging survivors from the Childhood Cancer Survivor Study on the basis of therapeutic exposu

230 d for symptom domains by using the Childhood Cancer Survivor Study sibling cohort.

231 >/= 25 years participating in the Childhood Cancer Survivor Study who received cardiotoxic therapy a

232 lation-based TYACSS (Teenage and Young Adult Cancer Survivor Study) (N=178,962) was linked to Hospita

233 who were participants in the CCSS (Childhood Cancer Survivor Study).

234 Data from the Childhood Cancer Survivor Study, a cohort of survivors of at least

235 21 survivors exposed to CRT in the Childhood Cancer Survivor Study, a diagnosis of meningioma and ons

236 siblings, all participants of the Childhood Cancer Survivor Study, completed three surveys assessing

237 75 to August 2009 collected in the Childhood Cancer Survivor Study, we show applications of mean cumu

238 d 14,359 5-year survivors from the Childhood Cancer Survivor Study, who were first diagnosed when the

239 erapy who were participants in the Childhood Cancer Survivor Study.

240 urvivors and 210 siblings from the Childhood Cancer Survivor Study.

241 son group who were enrolled in the Childhood Cancer Survivor Study.

242 thin the recently extended British Childhood Cancer Survivor Study.

243 are, among a low-income population of breast cancer survivors (survivors).

244 adverse health outcomes (AHOs) in testicular cancer survivors (TCSs) after four cycles of etoposide a

245 lts in better insomnia treatment outcomes in cancer survivors than CBT-I alone.

246 s and taxanes, is a widespread problem among cancer survivors that is likely to continue to expand in

247 Among previously diagnosed cancer survivors, the annual excess burden was $4,427 pe

248 ld involve discussions between providers and cancer survivors to address survivors' needs and optimiz

249 ence, it is reasonable to counsel colorectal cancer survivors to engage in regular physical activity

250 quences of cancer diagnosis and treatment in cancer survivors to enhance an integrated cancer service

251 Childhood cancer survivors treated with anthracyclines are at high

252 Arthralgia occurs in up to 50% of breast cancer survivors treated with aromatase inhibitors (AIs)

253 Childhood cancer survivors treated with cardiotoxic therapies are

254 breast cancer risk in 1,230 female childhood cancer survivors treated with chest irradiation who were

255 y, longitudinal reports of SNHL in childhood cancer survivors treated with contemporary RT are limite

256 Childhood cancer survivors treated with lower delivered doses of r

257 Prostate cancer survivors treated with radiation or ablative ther

258 diagnosis (as applicable) to non-HCT 2-year cancer survivors, using the state cancer registry (n = 5

259 initiation rates were significantly lower in cancer survivors versus the general population (23.8%; 9

260 the prevalence of HPV vaccine initiation in cancer survivors versus the US population and examined p

261 Rates of medication use in cancer survivors were compared with rates in the general

262 Overall, 2782 cancer survivors were hospitalized for a cerebrovascular

263 ors and two randomized trials in endometrial cancer survivors were identified.

264 ing the treatment of cancer and 53 childhood cancer survivors were involved in the study.

265 pared with adults with no history of cancer, cancer survivors were significantly more likely to repor

266 1), indicating that an estimated 2.5 million cancer survivors were taking medication for anxiety or d

267 nitude of pulmonary dysfunction in childhood cancer survivors when compared with healthy controls and

268 rs, we identified 53,032 hospitalizations in cancer survivors, whereas 38,423 were expected, resultin

269 tment approaches for the management of adult cancer survivors who are experiencing symptoms of fatigu

270 n primary care providers (PCPs) as receiving cancer survivors who are transferred after successful tr

271 improvement in therapies, the population of cancer survivors who can expect to live for 5 or more ye

272 study from April to July 2016, 10 pediatric cancer survivors who completed chemotherapy underwent im

273 erall survival was significantly worse among cancer survivors who developed CVD (60%) when compared w

274 Cancer survivors who developed CVD had an 11-fold increa

275 about the breast cancer risk among childhood cancer survivors who did not receive chest radiotherapy.

276 sseminated tumor cells in the bone marrow of cancer survivors who have been clinically disease free.

277 ure disease is poorly understood in prostate cancer survivors who have undergone radiation or ablativ

278 ad not yet initiated their treatment, and 54 cancer survivors who received either anthracycline-based

279 cancer patients, an analysis in 9514 breast cancer survivors who were followed for 7.4 y found that

280 Cancer survivors who were uninsured, had lower family in

281 For breast cancer survivors who wish to conceive, the risk of death

282 Approximately 4% to 5% of breast cancer survivors will develop a new ipsilateral or contr

283 derate to severe pain, most pain problems in cancer survivors will not require them.

284 One hundred breast cancer survivors with a body mass index >/= 25 kg/m(2) w

285 Forty-six long-term childhood cancer survivors with a cumulative anthracycline dose >/

286 Patients and Methods We recruited adult cancer survivors with a primary malignancy (excluding ce

287 ibitor and beta-blocker therapy in childhood cancer survivors with ALVD is undetermined (or unknown).

288 Conclusion Many (57%) older breast cancer survivors with an estimated short life expectancy

289 association study was conducted in childhood cancer survivors with and without cardiomyopathy (cases

290 tion, gait patterns, and falls between women cancer survivors with and without symptoms of CIPN to id

291 This randomized controlled trial included 88 cancer survivors with high FCR (Cancer Worry Scale score

292 Childhood cancer survivors with hypertension after anthracycline e

293 ual surveillance mammography in older breast cancer survivors with limited life expectancy are not kn

294 Pediatric cancer survivors with low BMD may benefit from low-magni

295 Breast cancer survivors with menopausal dyspareunia can have co

296 Cancer survivors with two or more CVRFs had the highest

297 provide coordinated, comprehensive care for cancer survivors, with an emphasis on the role of primar

298 ng is feasible and efficacious for childhood cancer survivors, with evidence for training-related neu

299 breast cancer risk in 3,768 female childhood cancer survivors without a history of chest radiotherapy

300 s who developed CVD (60%) when compared with cancer survivors without CVD (81%; P < .01).